BIOMAT Database Logo BIOMAT Database Logo

Antiretroviral therapy: reference guide to major clinical trials in patients infected with human immunodeficiency virus. 1995

K M Spooner, and H C Lane, and H Masur
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

K M Spooner, and H C Lane, and H Masur
Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors.
March 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K M Spooner, and H C Lane, and H Masur
Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
May 2002, The Journal of infectious diseases,
K M Spooner, and H C Lane, and H Masur
Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy.
October 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K M Spooner, and H C Lane, and H Masur
Antiretroviral therapy in drug-naive patients infected with human immunodeficiency virus.
July 2004, The American journal of the medical sciences,
K M Spooner, and H C Lane, and H Masur
Antiretroviral therapy in human immunodeficiency virus-infected individuals.
January 1998, Advances in internal medicine,
K M Spooner, and H C Lane, and H Masur
External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy.
December 2012, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus,
K M Spooner, and H C Lane, and H Masur
Clinical experience with human immunodeficiency virus-infected older patients in the era of effective antiretroviral therapy.
June 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K M Spooner, and H C Lane, and H Masur
Antiretroviral hepatotoxicity in human immunodeficiency virus-infected patients.
October 2001, Alimentary pharmacology & therapeutics,
K M Spooner, and H C Lane, and H Masur
Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus.
December 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
K M Spooner, and H C Lane, and H Masur
The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials.
April 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!